patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Free
Message: OT: patientman..apparently, we will be doing some more waiting lol

You are very right about Wall Street and PTSC, IMO.

I have a big position (for me) in PTSC and EDIG. PTSC should make a steady rise as new license deals are known and as a long term biz plan is unveiled by JT.

As for this one, I have not entered the water just yet. I do beleive this is a value play as soon as we can see some cash flow. It's just when. I hope I don't get caught waiting too long.

John

Share
New Message
Please login to post a reply